• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于阿尔茨海默病的双靶点化合物:天然和合成的乙酰胆碱酯酶及β-分泌酶-1双抑制剂及其构效关系

Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).

作者信息

Ferreira João P S, Albuquerque Hélio M T, Cardoso Susana M, Silva Artur M S, Silva Vera L M

机构信息

LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal.

LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal.

出版信息

Eur J Med Chem. 2021 Oct 5;221:113492. doi: 10.1016/j.ejmech.2021.113492. Epub 2021 Apr 24.

DOI:10.1016/j.ejmech.2021.113492
PMID:33984802
Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disease and represents the major cause of dementia worldwide. Currently, there are no available treatments capable to deliver disease-modifying effects, and the available drugs can only alleviate the symptoms. The exact pathology of AD is not yet fully understood and several hallmarks such as the presence of amyloid-β (Aβ) senile plaques, neurofibrillary tangles (NFTs) as well as the loss of cholinergic function have been associated to AD. Distinct pharmacological targets have been validated to address AD, with acetylcholinesterase (AChE) and β-secretase-1 (BACE-1) being two of the most explored ones. A great deal of research has been devoted to the development of new AChE and BACE-1 effective inhibitors, tackled separately or in combination of both. The multi-factorial nature of AD conducted to the development of multi-target directed ligands (MTDLs), defined as single molecules capable to modulate more than one biological target, as an alternative approach to the old paradigm one-target one-drug. In this context, this review describes a collection of natural and synthetic compounds with dual-inhibitory properties towards both AChE and BACE-1 in the MTDLs context. Furthermore, this review also provides a critical comprehensive analysis of structure-activity relationships (SAR) of the synthetic compounds.

摘要

阿尔茨海默病(AD)是一种慢性神经退行性疾病,也是全球痴呆症的主要病因。目前,尚无能够产生疾病修饰作用的有效治疗方法,现有的药物只能缓解症状。AD的确切病理尚未完全明确,其与一些特征有关,如β淀粉样蛋白(Aβ)老年斑、神经原纤维缠结(NFTs)以及胆碱能功能丧失。已验证了不同的药理学靶点来治疗AD,乙酰胆碱酯酶(AChE)和β-分泌酶-1(BACE-1)是研究最多的两个靶点。大量研究致力于开发新的AChE和BACE-1有效抑制剂,单独或联合进行研究。AD的多因素性质促使了多靶点导向配体(MTDLs)的发展,MTDLs被定义为能够调节多个生物靶点的单一分子,作为对传统单靶点单药物模式的替代方法。在此背景下,本综述描述了在MTDLs背景下对AChE和BACE-1均具有双重抑制特性的天然和合成化合物的集合。此外,本综述还对合成化合物的构效关系(SAR)进行了批判性的综合分析。

相似文献

1
Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).用于阿尔茨海默病的双靶点化合物:天然和合成的乙酰胆碱酯酶及β-分泌酶-1双抑制剂及其构效关系
Eur J Med Chem. 2021 Oct 5;221:113492. doi: 10.1016/j.ejmech.2021.113492. Epub 2021 Apr 24.
2
Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.寻找阿尔茨海默病的多靶标导向配体:具有 AChE、H₃R 和 BACE 1 抑制活性的基于喹喔啉的杂合化合物的发现。
Bioorg Med Chem. 2011 Dec 1;19(23):7158-67. doi: 10.1016/j.bmc.2011.09.061. Epub 2011 Oct 5.
3
Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.设计并合成多奈哌齐类似物作为双重乙酰胆碱酯酶和 BACE-1 抑制剂。
Bioorg Chem. 2018 Oct;80:245-252. doi: 10.1016/j.bioorg.2018.06.031. Epub 2018 Jun 25.
4
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.治疗阿尔茨海默病的新型小分子治疗药物:聚焦 BACE1 和多靶点定向配体。
Bioorg Chem. 2020 Apr;97:103649. doi: 10.1016/j.bioorg.2020.103649. Epub 2020 Feb 4.
5
Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.设计、合成及一些 2-(3-氧代-5,6-二苯基-1,2,4-三嗪-2(3H)-基)-N-苯乙酰胺杂合体作为阿尔茨海默病治疗的多靶点药物的研究。
Eur J Med Chem. 2024 May 5;271:116409. doi: 10.1016/j.ejmech.2024.116409. Epub 2024 Apr 16.
6
Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.基于结构的多奈哌齐结构刚性类似物作为双重乙酰胆碱酯酶和β-分泌酶-1抑制剂的设计、合成及评估
Bioorg Med Chem Lett. 2018 Sep 15;28(17):2910-2913. doi: 10.1016/j.bmcl.2018.07.019. Epub 2018 Jul 11.
7
Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.应用于一组抗乙酰胆碱酯酶抑制剂与β-分泌酶(BACE-1)的动态模拟、对接和密度泛函理论研究:阿尔茨海默病的一个重要治疗靶点
Curr Comput Aided Drug Des. 2017 Nov 10;13(4):266-274. doi: 10.2174/1573409913666170406150905.
8
Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.双结合位点乙酰胆碱酯酶抑制剂作为抗阿尔茨海默病药物的多功能特性的结构决定因素。
Curr Pharm Des. 2010;16(25):2818-36. doi: 10.2174/138161210793176536.
9
New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.新型基于硫辛酸的神经源性杂合物作为具有σ-1激动作用和β-分泌酶抑制作用的创新型阿尔茨海默病药物。
Future Med Chem. 2016 Jul;8(11):1191-207. doi: 10.4155/fmc-2016-0036. Epub 2016 Jul 12.
10
Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease.探索苯并氮杂衍生物作为 AChE、BACE1 的药效团以及作为抗 Aβ 聚集物,以寻找针对阿尔茨海默病的多靶化合物。
Molecules. 2024 Oct 9;29(19):4780. doi: 10.3390/molecules29194780.

引用本文的文献

1
Design, Synthesis, In Vitro, and In Silico Studies of 5-(Diethylamino)-2-Formylphenyl Naphthalene-2-Sulfonate Based Thiosemicarbazones as Potent Anti-Alzheimer Agents.基于5-(二乙氨基)-2-甲酰基苯基萘-2-磺酸盐的硫代氨基脲作为强效抗阿尔茨海默病药物的设计、合成、体外和计算机模拟研究
Arch Pharm (Weinheim). 2025 Jul;358(7):e70050. doi: 10.1002/ardp.70050.
2
Design, synthesis, and evaluation of pyrrole-indole hybrids as dual tubulin and aromatase inhibitors with potent anticancer activities.吡咯 - 吲哚杂合物作为具有强效抗癌活性的双微管蛋白和芳香化酶抑制剂的设计、合成及评估
RSC Adv. 2025 Jun 27;15(27):21962-21976. doi: 10.1039/d4ra09000d. eCollection 2025 Jun 23.
3
Novel fungal metabolites as dual cholinesterase inhibitors: A computational approach for Alzheimer's disease therapy.
新型真菌代谢产物作为双重胆碱酯酶抑制剂:用于阿尔茨海默病治疗的计算方法
PLoS One. 2025 Jun 16;20(6):e0326219. doi: 10.1371/journal.pone.0326219. eCollection 2025.
4
Exploration of Asparagus racemosus Willd for Alzheimer's Disease Through Integrated Metabolomics and Network Pharmacology Analyses Targeting BACE1 Protein.通过针对β-分泌酶1(BACE1)蛋白的综合代谢组学和网络药理学分析探索印度天门冬对阿尔茨海默病的作用
Neurochem Res. 2025 Jun 8;50(3):190. doi: 10.1007/s11064-025-04440-9.
5
Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules.通过靶向神经退行性相关酶缓解神经疾病:天然和合成分子
Int J Mol Sci. 2025 May 14;26(10):4707. doi: 10.3390/ijms26104707.
6
Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer's Disease.β淀粉样蛋白在阿尔茨海默病检测与治疗中的临床意义
Int J Mol Sci. 2025 Feb 24;26(5):1935. doi: 10.3390/ijms26051935.
7
Ginkgolide B as a biopsychosocial treatment salvages repeated restraint stress-induced amygdalar anomalies in mice.银杏内酯B作为一种生物心理社会疗法可挽救小鼠反复束缚应激诱导的杏仁核异常。
IBRO Neurosci Rep. 2024 Dec 18;18:66-77. doi: 10.1016/j.ibneur.2024.12.010. eCollection 2025 Jun.
8
Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on Research Advancements.天然芹菜素治疗阿尔茨海默病的疗效与安全性:聚焦研究进展
Curr Neuropharmacol. 2025;23(6):728-754. doi: 10.2174/1570159X23666241211095018.
9
Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE-1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies.通过计算机模拟、体外和体内研究鉴定大麻二酚酸和大麻大酚酸作为针对阿尔茨海默病的多靶点定向配体乙酰胆碱酯酶、丁酰胆碱酯酶和β-分泌酶-1抑制剂。
Phytother Res. 2025 Jan;39(1):233-245. doi: 10.1002/ptr.8369. Epub 2024 Nov 7.
10
Virtual screening, ADMET prediction, molecular docking, and dynamic simulation studies of natural products as BACE1 inhibitors for the management of Alzheimer's disease.基于虚拟筛选、ADMET 预测、分子对接和动态模拟研究的天然产物作为 BACE1 抑制剂用于阿尔茨海默病治疗。
Sci Rep. 2024 Nov 2;14(1):26431. doi: 10.1038/s41598-024-75292-6.